Status:
COMPLETED
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Lead Sponsor:
Nobelpharma
Conditions:
Wilson's Disease
Eligibility:
All Genders
1+ years
Phase:
PHASE3
Brief Summary
The purpose of this long-term study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
Detailed Description
Wilson disease is an autosomal recessive disorder with copper metabolism. In Japan, the standard treatment is the use of copper chelating agents, such as D-penicillamine and trientine. In this study, ...
Eligibility Criteria
Inclusion
- Wilson's disease(adult, infant, pregnant woman)
Exclusion
- Acute hepatitis
- Malignant tumor
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00212355
Start Date
March 1 2005
End Date
January 1 2009
Last Update
March 5 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.